NEW YORK, June 18, 2018 /PRNewswire/ -- WeissLaw LLP
is investigating possible breaches of fiduciary duty and other
violations of law by the Board of Directors of China Biologic
Products Holdings, Inc. ("CBPO" or the "Company") (NASDAQ: CBPO) in
connection with the proposed acquisition of the Company by Chinese
investment firm CITIC Capital Holdings Ltd. Under the terms
of the acquisition agreement, CBPO shareholders will receive
$110 in cash for each share they
own.
WeissLaw is investigating whether CBPO's Board acted to maximize
shareholder value prior to entering into the agreement.
Notably, the per-share offer price is nearly $5.00 less than the Company's 52-week high of
$114.82, and $22.00 less than the analyst target price of
$132.00 per share.
Given these facts, WeissLaw is investigating whether CBPO's
Board acted in the best interests of CBPO's public shareholders to
maximize shareholder value prior to entering into the
agreement. If you own CBPO shares and would like more
information about your rights or our investigation, or if you have
information to share with us, please contact Joshua Rubin by telephone at
(888) 593-4771 or by email at
stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com or fill out the form
on our website,
http://www.weisslawllp.com/china-biologic-products-holdings-inc/
View original
content:http://www.prnewswire.com/news-releases/weisslaw-llp-investigates-china-biologic-products-holdings-inc-300668056.html
SOURCE WeissLaw LLP